EDAS Healthcare provides instant lab-grade AI detection of respiratory infectious diseases and COVID-19 for use in primary care and telemedicine. The companys solution detects the patients specific infecting pathogen using only anonymous patient demographics and without any physical tests or equipment. EDAS aims to significantly improve treatment quality, reduce primary care costs, and reduce the overuse of antibiotics while enabling diagnosis via telemedicine.